Location History:
- Abingdon, GB (2021)
- Reading, GB (2022)
Company Filing History:
Years Active: 2021-2025
Title: The Innovations of Peter Neville Ingram
Introduction
Peter Neville Ingram is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of medical science, particularly in the development of compounds that modulate the calcium-activated chloride channel (CaCC), TMEM16A. With a total of 3 patents, Ingram's work is focused on addressing respiratory diseases and conditions.
Latest Patents
Ingram's latest patents include innovative compounds characterized by a general formula that serves as positive modulators of TMEM16A. These compounds are particularly useful for treating diseases and conditions that are influenced by the modulation of TMEM16A, especially respiratory ailments. The detailed formulations of these compounds highlight their potential therapeutic applications.
Career Highlights
Throughout his career, Peter Neville Ingram has worked with various companies, including Tmem16a Limited and Haplogen GmbH. His expertise in the field has allowed him to contribute to advancements in medical treatments and therapies.
Collaborations
Ingram has collaborated with notable individuals in his field, including Stephen Collingwood and Clive McCarthy. These partnerships have further enhanced his research and development efforts.
Conclusion
Peter Neville Ingram's contributions to the field of medical science through his innovative patents and collaborations underscore his importance as an inventor. His work continues to pave the way for advancements in the treatment of respiratory diseases.